Minimally invasive procedures for uterine fibroids are highly effective, but gaps in diagnosis, racial disparities, and lack of availability outside urban academic centers limit their use.
REDWOOD CITY, Calif., Aug. 01, 2023 (GLOBE NEWSWIRE) Gynesonics®, Inc. a women’s healthcare company focused on the development of minimally invasive.